Antineoplastic Agents, Immunological
3 clinical trials · Condition
◉ Watch Antineoplastic Agents, Immunological
| Record | Firm | Date |
|---|---|---|
| Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer (NCT07124858) | Federation Francophone de Cancerologie Digestive | 2026-03-10 |
| Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer (NCT06134193) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-11-01 |
| Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma (NCT04572451) | Yana Najjar | 2021-11-29 |
Track Antineoplastic Agents, Immunological automatically
Every clearance here is in the API, with alerts when new ones post.